Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced that it has completed the acquisition of Urotronic, Inc. (Urotronic), a private medical device company that developed Optilume® drug-coated balloon technology used in interventional urology to treat urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions. Urotronic and its employees will be fully integrated into the Laborie business as part of the transaction.
Read the full article: Laborie Medical Technologies Acquires Urotronic //
Source: https://www.prnewswire.com/news-releases/laborie-medical-technologies-acquires-urotronic-301970161.html